Value of exported pharmaceutical drugs from Japan 2013-2022
In 2022, the value of Japanese pharmaceutical drug exports amounted to approximately 649 billion Japanese yen. The figure increased compared to approximately 563 billion Japanese yen in the previous year.
Export partner countries
When it comes to exports of pharmaceutical drugs, the United States were the largest partner country for Japan with the highest share of the total value, followed by Switzerland. In recent years, Japan sent around 167 billion Japanese yen of pharmaceutical drug exports to the USA. In terms of a broader geographical area, Europe was the region in which most of the pharmaceutical exports from Japan were delivered to.
Mainly exported agents
When classifying agents into therapeutic categories, antineoplastic drugs that did not fall into other categories accounted for roughly 16 percent of the total value of drug exports from Japan in recent years. Other biological agents followed as the second largest category. Other antineoplastic agents refer to agents which do not belong to the classification of alkylating agents, antimetabolite, antitumor antibiotics and preparations, and antineoplastic preparations extracted from plants.
